RxDoctor Payments Data

Jeannette Acevedo Rivera, MD

Psychiatry · Brownsville, TXNPI 1235530270

Payments from drug & device makers

$1,533in general payments, 2019–2025

Across 98 payments — averaging $15.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$503
  • AbbVie$276
  • Alkermes, Inc.$240
  • Otsuka America Pharmaceutical, Inc.$190
  • Johnson & Johnson$116
  • Vanda Pharmaceuticals Inc.$45
  • plus $164 from 7 others

What the payments were for

  • Food & beverage$1,43393%
  • Education$1007%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,533 in reported general payments places this provider in the 75th percentile of 2,238 psychiatry providers in Texas.

See all psychiatry providers in Texas

Medicare billing

Part B allowed, 2024
$7,523
Medicare patients
36
Services billed
97

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine37$265,348
Invega TrinzaPaliperidone Palmitate19$156,255
Invega SustennaPaliperidone Palmitate42$149,788
VraylarCariprazine Hcl22$33,458
RexultiBrexpiprazole25$22,354
TrintellixVortioxetine Hydrobromide33$16,437
BelsomraSuvorexant27$12,916
Oxcarbazepine85$4,701
Divalproex Sodium ErDivalproex Sodium55$3,267
Trazodone Hcl268$2,740
Olanzapine145$2,564
Hydroxyzine Hcl175$2,487
Olanzapine OdtOlanzapine17$2,204
Fluphenazine Hcl21$2,149
Buspirone Hcl146$2,131

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Trinza, Invega Sustenna$116$306,04261 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$503$265,34837 claims
AbbVieVraylar$276$33,45822 claims
Otsuka America Pharmaceutical, Inc.Rexulti$190$22,35425 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$13$16,43733 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,238 psychiatry providers in Texas.

Other psychiatry in Brownsville

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →